Undiagnosed Fabry disease: the importance of screening for Fabry disease before transcutaneous patent foramen ovale closure in a young patient with cryptogenic stroke

J Cardiovasc Med (Hagerstown). 2020 Sep;21(9):711-713. doi: 10.2459/JCM.0000000000000952.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Cardiac Catheterization* / instrumentation
  • Enzyme Replacement Therapy
  • Fabry Disease / complications
  • Fabry Disease / diagnosis*
  • Fabry Disease / drug therapy
  • Female
  • Foramen Ovale, Patent / complications
  • Foramen Ovale, Patent / diagnostic imaging
  • Foramen Ovale, Patent / therapy*
  • Humans
  • Isoenzymes / therapeutic use
  • Recombinant Proteins / therapeutic use
  • Risk Factors
  • Septal Occluder Device
  • Stroke / diagnosis
  • Stroke / etiology
  • Stroke / prevention & control*
  • Treatment Outcome
  • alpha-Galactosidase / therapeutic use

Substances

  • Isoenzymes
  • Recombinant Proteins
  • agalsidase alfa
  • alpha-Galactosidase

Supplementary concepts

  • Fabry Disease, Cardiac Variant